Skip to main content
TipRanks
Go Ultimate75% OFF

Urogen Pharma (URGN) Ownership - Who Owns Urogen Pharma?

677 Followers

Urogen Pharma (URGN) Ownership Overview

  • 1.77% Insiders
  • 5.60% Mutual Funds
  • 53.35% Other Institutional Investors
  • 7.51% ETFs
  • 31.77% Public Companies and Individual Investors

The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail, and individual investors. Approximately 66.46% of the company’s stock is owned by Institutional Investors, 1.77% is owned by Insiders, and 31.77% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 23, 2026Mark Schoenberg$2,854,853
Feb 03, 2026Mark Schoenberg$145,174

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Robert Bender&associates$1,409,902
Sep 30, 2026Ark Investment Management Llc$2,204,178
Sep 30, 2026 $126,286,247
Sep 30, 2026Gilder Gagnon Howe & Co Llc.$1,224,913

Top Shareholders

URGN top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.3,108,202Institution6.34%87,340,476
Ishares2,260,672Institution4.61%63,524,883
American Century Mutual Funds, Inc.874,981Institution1.78%24,586,966
Fidelity Salem Street Trust507,789Institution1.04%14,268,871
Michael Rockefeller500,726Institution1.02%14,070,401
Vanguard470,752Institution0.96%13,228,131
Vanguard Scottsdale Funds420,842Institution0.86%11,825,660
Arie Belldegrun408,693Insider0.83%11,484,273
Elizabeth A. Barrett326,691Insider0.67%9,180,017
Fidelity256,406Institution0.52%7,205,009

Top Mutual Fund Holders

URGN top mutual fund holders
Holder# of SharesType% HoldingValue
American Century Mutual Funds, Inc.874,981Institution1.78%24,586,966
Fidelity Salem Street Trust507,789Institution1.04%14,268,871
Vanguard Scottsdale Funds420,842Institution0.86%11,825,660
Tiaa-cref Funds158,899Institution0.32%4,465,062
Schwab Capital Trust126,848Institution0.26%3,564,429
Vanguard World Fund118,428Institution0.24%3,327,827
Valic Co I113,987Institution0.23%3,203,035
Clearwater Investment Trust67,706Institution0.14%1,902,539
Federated Hermes Mdt Series60,521Institution0.12%1,700,640
Russell Investment Co46,964Institution0.10%1,319,688

Top ETF Holders

URGN top ETF holders
Holder# of SharesType% HoldingValue
iShares Russell 2000 ETF, IWM ETF1,107,721Institution2.26%29,000,136
iShares Russell 2000 Growth ETF, IWO ETF344,632Institution0.70%9,022,466
iShares Biotechnology ETF, IBB ETF319,191Institution0.65%8,969,267
Vanguard Russell 2000 ETF, VTWO ETF250,505Institution0.51%8,196,524
Fidelity Enhanced Small Cap ETF, FESM ETF220,902Institution0.45%5,783,214
SPDR Portfolio Developed World ex-US ETF, SPDW ETF194,821Institution0.40%5,100,414
iShares Micro-Cap ETF, IWC ETF129,134Institution0.26%3,628,665
Vanguard Health Care ETF, VHT ETF120,183Institution0.25%3,932,388
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR, FR:R2EH ETF72,019Institution0.15%1,900,581
ARK Israel Innovative Technology ETF, IZRL ETF65,657Institution0.13%1,844,962

FAQ

Who Owns Urogen Pharma (URGN)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 66.46% of the company's stock is held by institutional investors, 1.77% is held by insiders, and 31.77% is held by public companies and individual investors.
What percentage of Urogen Pharma (URGN) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 66.46% of Urogen Pharma (URGN) stock is held by institutional investors: 5.60% by mutual funds, 7.51% by ETFs and 53.35% by other institutional investors.
What percentage of Urogen Pharma (URGN) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 31.77% of Urogen Pharma (URGN) stock is held by public companies and individual investors.
Who owns the most shares of Urogen Pharma (URGN)?
BlackRock, Inc. owns the most shares of Urogen Pharma (URGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.